Jeffrey Arcara
Corporate Officer/Principal at CORVUS PHARMACEUTICALS, INC.
Net worth: - $ as of 2024-03-30
Profile
Jeffrey Arcara is currently the Chief Business Officer at Corvus Pharmaceuticals, Inc. He previously worked as the Vice President of Business Development at Neuromed Pharmaceuticals Ltd.
He received an undergraduate degree from the University of Wisconsin and an MBA from UCLA Anderson School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-27 | 0 ( -.--% ) | - $ | 2024-03-30 |
Jeffrey Arcara active positions
| Companies | Position | Start |
|---|---|---|
| CORVUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2024-02-05 |
Former positions of Jeffrey Arcara
| Companies | Position | End |
|---|---|---|
Neuromed Pharmaceuticals Ltd.
 Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals Ltd. develops chronic pain drugs. Its NMED-1077 product is an extended release formulation of hydromorphone in phase 3 clinical development. It conducts research for drugs to cure anxiety, epilepsy, hypertension, and cardiovascular diseases. The company was founded by Dr. Terrance P. Snutch in 1998 and is headquartered in Vancouver, BC. | Corporate Officer/Principal | 2010-01-26 |
Training of Jeffrey Arcara
| University of Wisconsin | Undergraduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CORVUS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Neuromed Pharmaceuticals Ltd.
Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals Ltd. develops chronic pain drugs. Its NMED-1077 product is an extended release formulation of hydromorphone in phase 3 clinical development. It conducts research for drugs to cure anxiety, epilepsy, hypertension, and cardiovascular diseases. The company was founded by Dr. Terrance P. Snutch in 1998 and is headquartered in Vancouver, BC. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Arcara
